Biomarker Trends, Incidence, and Outcomes of Immune Checkpoint Inhibitor-Induced Myocarditis.
JACC CardioOncol
; 4(5): 689-700, 2022 Dec.
Article
em En
| MEDLINE
| ID: mdl-36636441
ALT; ALT, alanine aminotransferase; AST; AST, aspartate aminotransferase; CPK; CPK, creatine phosphokinase; ICI, immune checkpoint inhibitor; LDH, lactate dehydrogenase; ULN, upper limit of normal; biomarkers; hsTnT, high-sensitivity troponin T; immune checkpoint inhibitor; immunotherapy; irAE, immune-related adverse event; myocarditis; troponin
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Tipo de estudo:
Incidence_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article